It’s still open season for bio-piracy
Rich nations block accord on benefit-sharing rules for the world’s genetic resources
Whose germplasm is it?
NBA struggles to frame case against Mahyco in first biopiracy case
What's with this Kolaveri about John Doe injunctions?
In jurisdictions where the law of copyright is much more matured as compared to India, the injunctions are issued very judiciously, and by …
Gunning for green tech
US continues to target India over its intellectual property regime, especially in pharma, green tech sectors
Gopal Subramaniam, Rohinton Nariman swap places in Novartis patent case
Will take on each other in the patent case of anti-cancer drug Glivec filed by Novartis
Choking access to drugs
Drug prices are likely to increase as rich countries and their pharma companies squeeze Indian generics out of the market. How can India’s …
Future compromised
The Earth Summit was a historical opportunity to set the world on the correct development trajectory. Negotiators from 191 countries came …
Patent hypocrisies of US
American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards
Any cheers for Doha pact?
The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities
No climate for cleantech
Most of the clean energy innovations are with just six rich countries and hardly any technology is coming to developing nations
Caution: pastures ahead
Costly silence
No one is debating where goats will graze
A lethal secrecy in trade deals
Why do democratic governments hide trade negotiations that have dire consequences for public services?
Pursuing a nationalist IPR policy
India has enough laws to protect its intellectual property rights. It is the implementation that is wanting
The pirates come ashore
German Pirate Party’s strong showing in the May elections is a sign that anti-IPR movements resonate with the people
Patent issues delaying Ebola cure
Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine
ACTA fury goes viral
Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar
Sub-standard drugs bigger problem than counterfeit drugs: health activists
Problem of poor quality drugs cannot be solved with technology alone, they say
Say cheese to Brussels
Global report on challenges faced by seed sector launched
Focuses on need to stop seed laws that are preventing farmers from saving and exchanging their indigenous varieties
What Durban did not discuss
IPRs are blocking access to mitigation and adaptation technologies. India offers a way out
New endosulfan ploy
Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
Return of village land
Supreme Court asks states to evict illegal occupants of village commons
Letters